The total duration of the study is between 7 to 8 months and will include 12 or fewer visits to a study center near you.
There is no cost to take part in the MaSQue Clinical Investigation, in addition, participants will receive reimbursement for travel expenses and costs associated with their participation.
You may qualify to participate in the MaSQue Clinical Investigation if you:
* The safety and efficacy of has not been proven to improve skin quality, but it was demonstrated to be safe and tolerable in other clinical trials involving a small number of participants with stretch marks and atrophic acne scars.
What happens if I sign up? We will match you to a study center in your area that needs volunteers or notify you when one becomes available. The study team will then contact you and you may have the opportunity to participate if qualified.
If you think you might like to participate in the MaSQue Clinical Investigation or would like more information, please enter your information below so we can see if you may qualify and can contact you about the studies. Keep in mind that participation is entirely voluntary. If you do decide to take part in a study, you may change your mind about participating at any time.
A clinical investigation, also known as a clinical trial, is carefully designed medical research with human volunteers to learn more about a clinical investigational drug or device. A clinical investigational drug or device is a potential treatment that has not been approved for use outside of the clinical investigation by national health authorities. The safety and efficacy of the investigational drug or device have not yet been established. Volunteers may have different reasons for participating in a clinical trial, including contributing to the advancement of science.
The MaSQue Clinical Investigation is an open-label clinical investigation of the safety and effectiveness of intradermal injections of injectable gel for multiple attributes of skin quality in healthy adults. An open-label clinical investigation is one in which both the clinical trial participants and the clinical trial staff are aware of the treatment being given.
Total clinical investigation duration is approximately 7 to 8 months:
The research team will be able to explain more about what the MaSQue Clinical Investigation will involve, and it is up to you to decide if you want to take part. Participation in this study is voluntary. Whether or not you decide to participate in this study will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships.
The MaSQue Clinical Investigation is an open-label clinical investigation of the safety and effectiveness of intradermal injections of injectable gel for multiple attributes of skin quality in healthy adults. An open-label clinical investigation is one in which both the clinical trial participants and the clinical trial staff are aware of the treatment being given.
All qualifying participants will receive the injectable gel in their cheeks. Skin quality comprises attributes such as fine lines, skin texture, elasticity, skin tone, and pore size. Over time, aging and environmental factors affect the structure and function of the skin, leading to changes in its elastic properties and to visible aging. The clinical investigation will evaluate the safety and effectiveness of injectable gel, as measured by investigator assessments as well as participant responses.
Factors such as pore size, skin tone, radiance, smoothness, dynamic movement, hydration, structure, elasticity, thickness and density will be measured.
If you decide to participate, your health will be closely monitored, and your privacy protected.
What will my commitment look like?
Total clinical investigation duration is approximately 7 to 8 months:
You may qualify to participate in the MaSQue Clinical Investigation if you:
* The safety and efficacy of has not been proven to improve skin quality, but it was demonstrated to be safe and tolerable in other clinical trials involving a small number of participants with stretch marks and atrophic acne scars.